ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
5,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
7,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
9,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
9,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
9,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
10,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
10,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Headache,Headaches NEC,Headaches,Nerv,N
14,1,Acute haemorrhagic conjunctivitis,Enteroviral infections NEC,Viral infectious disorders,Infec,N
14,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
14,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
14,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
14,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
14,7,Headache,Headaches NEC,Headaches,Nerv,N
14,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
14,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
14,11,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
14,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
14,13,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,14,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,15,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
14,16,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
14,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
16,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
17,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
18,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
19,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
20,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
22,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
22,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
22,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
23,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
24,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
26,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
26,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
27,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
27,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
27,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
27,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
28,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
28,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
28,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
28,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
28,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
29,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
29,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
30,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
31,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
31,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
32,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
32,3,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
32,4,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
32,5,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
32,6,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
32,7,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
32,8,Cloacal exstrophy,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
32,9,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
32,10,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
32,11,Congenital genital malformation,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
32,12,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
32,13,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
32,14,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
32,15,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,16,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,17,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,18,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
32,19,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
32,20,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,21,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,22,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
32,23,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
32,24,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
32,25,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
32,26,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
32,27,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
32,28,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
32,29,Musculoskeletal deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
32,30,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
32,31,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
32,32,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
32,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
32,34,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
32,35,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
32,36,Tethered cord syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
32,37,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
32,38,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
33,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
33,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
33,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
33,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
34,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
35,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
36,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
36,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
37,1,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
38,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
38,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
39,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
40,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
40,2,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
40,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
40,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
41,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
41,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
41,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
43,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
44,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
45,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
45,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
45,3,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
46,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
46,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
47,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
48,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
49,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
49,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
49,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
50,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
51,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
51,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
52,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
52,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
52,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
54,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
54,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
54,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
55,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
56,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
57,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
58,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
59,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
59,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
60,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
60,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
61,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,2,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
63,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
64,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
65,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
67,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
67,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
67,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
67,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
67,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
67,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
67,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
68,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
68,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
69,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
69,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
69,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
69,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
70,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,1,Headache,Headaches NEC,Headaches,Nerv,N
73,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
74,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
75,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
76,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
76,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
77,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
77,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
78,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
80,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
80,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
80,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
80,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
80,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
80,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
80,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
80,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
80,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
83,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
84,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
84,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
85,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
88,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
89,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
90,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,2,Waist circumference increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Intervertebral disc injury,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
93,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
94,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
96,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
96,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
96,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
96,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
96,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
96,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
96,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
96,10,Weight loss poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
97,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
97,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
98,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
99,1,Urine electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
100,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
100,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
101,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
102,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
103,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
105,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
107,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
109,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
110,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
112,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
113,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
114,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
